Inventor · disambiguated record
Olaf Hardt
Also filed as: HARDT OLAF · HARDT OLAF THORSTEN
5 granted patents·7 pending applications·12 citations·filing 2015–2021
71Inventor score
Top patents by PatentIndex Score
12 records- 0186US10617720B2Chimeric antigen receptor specific for tumor cellsMILTENYI BIOTEC GMBH·Filed 2017·Granted Apr 14, 2020·4 cites·4 claims
- 0281US10273295B2Chimeric antigen receptor specific for SSEA4 antigenMILTENYI BIOTEC GMBH·Filed 2015·Granted Apr 30, 2019·8 cites·13 claims
- 0365US12161705B2Chimeric antigen receptor specific for tumor cellsMILTENYI BIOTEC BV & CO KG·Filed 2020·Granted Dec 10, 2024·0 cites·2 claims
- 0461US2021085769A1Chimeric antigen receptor specific for tumor cellsMILTENYI BIOTEC BV & CO KG·Filed 2020·Application pending·0 cites
- 0555US2023390393A1Chimeric antigen receptor comprising an antigen binding domain specific for msln having a specificity for tumor cellsMILTENYI BIOTEC BV & CO KG·Filed 2021·Application pending·0 cites
- 0654US2022364147A1Color and bardcoded beads for single cell indexingMILTENYI BIOTEC BV & CO KG·Filed 2020·Application pending·0 cites
- 0751US2023076164A1Method for providing personalized cells with chimeric antigen receptors (CAR) against tumor microenvironment cellsMILTENYI BIOTEC BV & CO KG·Filed 2021·Application pending·0 cites
- 0847US12221630B2Cell culture medium and method for generation of epithelial organoids from epithelial stem cellsMILTENYI BIOTEC BV & CO KG·Filed 2020·Granted Feb 11, 2025·0 cites·9 claims
- 0947US2020299404A1Method for providing personalized cells with chimeric antigen receptors (CAR)MILTENYI BIOTEC BV & CO KG·Filed 2020·Application pending·0 cites
- 1045US2022145247A1Generation of human pluripotent stem cell derived artificial tissue structures without three dimensional matricesMILTENYI BIOTEC BV & CO KG·Filed 2020·Application pending·0 cites
- 1141US10012647B2Depletion of mouse cells for isolation of human cellsMILTENYI BIOTEC GMBH·Filed 2015·Granted Jul 3, 2018·0 cites·6 claims
- 1226US2015316556A1Ssea4 and st3gal2 as chemotherapeutic drug response biomarkersMILTENYI BIOTECH GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Olaf Hardt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →